期刊文献+

晚期肿瘤患者深静脉血栓形成的危险因素分析 被引量:7

An Analysis on Risk Factors for Deep Venous Thrombosis in Patients with Advanced Cancer
原文传递
导出
摘要 [目的]探讨晚期肿瘤患者发生深静脉血栓的危险因素。[方法]采用回顾性分析方法,对2005年1月至2010年12月期间发生深静脉血栓的78例晚期肿瘤患者的临床资料进行分析,同时随机选择同期不伴有血栓性疾病的78例恶性肿瘤患者为对照,分析晚期肿瘤患者深静脉血栓形成的危险因素。[结果]多因素分析显示,并发感染(OR=3.249,P=0.038)、输血(OR=1.460,P=0.041)及远处转移(OR=7.376,P<0.001)是晚期肿瘤患者发生深静脉血栓的独立危险因素,病例组1年生存率明显低于对照组(41.0%vs52.6%,χ2=4.991,P=0.025)。[结论]远处转移、并发感染、输血治疗是晚期肿瘤患者发生深静脉血栓的危险因素,发生深静脉血栓者预后较差。 [Purpose] To investigate the risk factors for deep venous thrombosis(DVT) in patients with advanced cancer.[Methods] The clinical data of 78 advanced cancer patients(observation group) with DVT from January 2005 to December 2010 were analyzed retrospectively.And 78 advanced cancer patients without DVT were selected as the control group.The risk factors for DVT in patients with advanced cancer were analyzed.[Results] Multiple factor analysis showed that complicated with infection(OR=3.249,P=0.038),blood transfusion(OR=1.460,P=0.041) and distant metastasis(OR=7.376,P0.001) were the independent risk factors to advanced cancer patients with DVT.The 1-year survival rate in observation group was lower than that in control group(41.0% vs 52.6%,P=0.025).[Conclusion] Distant metastasis,infection and blood transfusion are the risk factors for DVT in patients with advanced cancer,and the prognosis of patients with DVT is poor.
作者 于雷
出处 《中国肿瘤》 CAS 2012年第12期956-959,共4页 China Cancer
关键词 恶性肿瘤 深静脉血栓 危险因素 输血 感染 cancer deep venous thrombosis risk factors transfusion infection
  • 相关文献

参考文献10

  • 1Khorana A A,Francis CW,Culakova E,et al.Thromboem- bolism is a leading cause of death in cancer patients re-ceiving outpatient chemotherapy[J].Thromb Haemost,2007, 5(3):632-634.
  • 2Lee AY,Levine MM. Venous thromhoembolism and cancer. risk and outcomes [J]. Circulation,2003,107 (23 Suppl 1): 17-21.
  • 3White RH. The epidemiology of venous thrnmboembolism [J].Circulation, 2003,107(23 Suppl 1):14-18.
  • 4Srensen HT,Mellemkjaer L,Olsen JH,et al.Prognosis of cancers associated with venous thromboenlholisnl[J]. N Engl J Med, 2000,343(25): 1846-1850.
  • 5Cardiovascular Disease Education and Research Trust, Cyprus Cardiovascular Disease Educational and Research Trust,European V~nous Forum,et al. Prevention and treatment of venous thromboembolism.International Con- sensus statement (guidelines according to scientific evi-dence) [J ]. Int Angiol, 2006,25(2): 101 - 161.
  • 6Blom JW,Doggen CJ,Osanto S,et al. Malignancies,pro- thrombotic mutations,and the risk of venous thrombosis [J].JAMA, 2005,293(6):715-722.
  • 7Khorana AA,Francis CW, Blumberg N,et al. Blood trans- fusions,thrombosis and mortality in hospitalized cancer patients [J]. Arch Intern Med,2008,168(21): 2377-2381.
  • 8Shorr AF,Williams MD. Venous thromboembolism in criti- cally ill patients. Observations from a randomized trial in sepsis[J].Thromb Haemost,2009,101(1):139-144.
  • 9Khorana AA, Francis CW,Culakova E,et al. Risk factors, and trends for venous thromboembolism among hospital cancer patient [J]. Cancer,2007, 110(10):2239-2346.
  • 10Weill-Engerer S,Meaume S,Lahlou A,et al.Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control muhicenter study [J]. J Am Geriatr Soc,2004, 52(8): 1299-1304.

同被引文献50

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部